Coronavirus (Covid-19) Executive Briefing
Understanding the economic impact of the Covid-19 pandemic and the implications for the healthcare sector
- ECONOMIC IMPACT -
Economists and institutions have cut their forecasts and experts are predicting the potential onset of recessionary environments.
Global companies are also concerned about the rising risk of Covid-19, with thousands of the world’s leading companies explicitly mentioning its impact on their business in their latest company filings.
-4.7%
The IMF estimates growth of -4.7% for the Middle East and Central Asian region.
9.5%
Goldman Sachs expects UK unemployment to rise to 9.5% by December 2020 because its job retention scheme ends in October.
Maximum, Minimum and Mean of all new GDP growth estimates by week
- SECTOR IMPACT: MEDICAL -
As of 29 July 2020
CardiovASCULAR Devices
Among the cardiovascular markets, pacemakers have been particularly hit by the pandemic. GlobalData estimates the US market for pacemaker devices was worth $782m in 2019, but as a result of Covid-19, the 2020 market value has been cut by around 50% of previous estimates for 2020, to $400m, with the market not recovering to a status resembling pre-Covid-19 until 2022.
15.7%
The Spinal Fusion market is expected to contract by 15.7% in 2020, and slowly recover during 2021.
General Surgery Devices
29
In the US, more than 29 states have allowed the resumption of general surgeries but under strict guidelines to prevent further Covid-19 infection.
Key mediCal market developments
Share this article